Medical technology

It is no coincidence that the Greater Zurich Area is home to so many world-class patents for medical technology as nowhere else in Europe. Technology leaders such as Roche Diagnostics, Zimmer Biomet, Stryker, Hamilton, Sonova, Cardinal Health and DePuy Synthes (Johnson&Johnson) operate headquarters or research and production facilities here. They value the large pool of international specialists, the R&D collaborations with leading universities and start-ups, the protection of intellectual property and the business-friendly environment. Would your medtech company also like to write a success story in Switzerland?

Switzerland is considered to be one of the world's most important locations for medical technology. The Greater Zurich Area contributes significantly to this. In fact, there is no other location in the world where medical technology is of such high importance in relation to total gross domestic product and labor force. Access to highly qualified specialists, first-class universities and research institutions such as the University of Zurich (UZH), the University Hospital Zurich (USZ), the ETH Zurich, and also the renowned Balgrist University Hospital are crucial assets. Leading and internationally recognized medical experts as well as developers and programmers conduct research to reduce or completely eliminate diseases of the human musculoskeletal system.

An example of successful cooperation between research and industry is the collaborative work of the UZH Clinic Balgrist and the medtech company HOCOMA. They are jointly developing robotic and sensor-based devices for functional movement therapy. Meanwhile, HOCOMA has even become one of the world market leaders in this field. 

Medical clinics, physiotherapists, rehabilitation centres or even fitness studios work together in a holistic approach so that the patient can benefit from modern and individual care. The medical technology in Greater Zurich aims for the best quality and quick access to innovations for the patients so that Switzerland remains an attractive and successful place for research and work. 

Thanks to the innovative Swiss spirit, new medical technology products are in great demand on the world market. According to Swiss MedTech, 85% of all the imports from the top 10 importing countries are medtech imports. The USA ranks first, followed by Germany and the Netherlands. More than half (55%) of all Swiss medtech products are imported from the USA and Germany.

A large number of medtech companies in the Greater Zurich Area

The medtech industry covers 12 fields of main applications. At the top are companies that manufacture materials for hospital supplies, orthopaedics, rehabilitation, prosthetics and orthotics. Manufacturers for wound care and for diabetes and ear, nose and throat applications are the taillight. From plasters to hearing aids, pacemakers or laboratory equipment for orthopaedics and care to hospital equipment, everything is produced. The Greater Zurich location consequently has a high density of medtech companies that are covering the entire value chain. They are all working to improve the quality of life worldwide and to guarantee optimal patient care with the help of medical technologies.

In comparison with seven leading European business locations, Greater Zurich Area has the highest number of patents in medical technology - both in terms of quantity and quality (world-class patents). (Source: BAK Economics)

There are a total of around 1400 medical technology companies in Switzerland. These create over 58,000 jobs. Most of the highly specialized manufacturers, suppliers and dealers are located in the Greater Zurich Area. Some of the top medtech companies include Cardinal Health, DePuy Synthes (Johnson & Johnson), Hamilton, Roche Diagnostics, Stryker, and Zimmer Biomet.

Why Greater Zurich for Medical Technology?

The Greater Zurich Area is unique. Knowledge and experience are exchanged within individual research departments but also between different companies and institutions. This creates a remarkable symbiosis of fruitful cooperation in the Swiss medtech industry. Universities and technology institutes offer various specialized biomedical master programs and doctoral programs, and hospitals or companies from related industries cooperate.  Medical technology thus combines academic knowledge with technical know-how and craftsmanship. This exchange specifically promotes innovation. The medical technology sector also benefits from the medical sector and smaller technology companies. These so-called micro-enterprises with fewer than ten employees also share highly specialized know-how with the medtech industry. This creates new opportunities such as the establishment of new specialised companies or takeovers.

Life sciences in the Greater Zurich Area

Life sciences in the Greater Zurich Area

Do you want to be close to major players, innovative start-ups and leading research institutes in the life sciences space? The Greater Zurich Area has evolved into a dynamically expanding life sciences hotspot, thanks to the region’s academic excellence, business-friendly regulations, IP protection, large international talent pool and R&D collaborations between universities and start-ups, as well as large multinational corporations.

Life Science Teaser

Innovation and collaboration 

Innovations can only make a difference, if they are safe, effective and applicable. As digitization is creating many new forms of medical technology, medtech companies in Greater Zurich are collaborating together in order to explore new approaches and create the best possible results through partnerships and shared knowledge.

Internationally focused

Switzerland is a prosperous and economically liberal country with an excellent infrastructure. Highly trained specialists and comparatively low tax rates offer good conditions for international companies. The generally low tax level for companies and - depending on the canton - also for the people living there is another advantage.

Greater Zurich stands out

The immediate proximity to one of the world's most important financial centers provides favorable conditions, especially for new companies. Various types of financing such as venture capital or private equity funds are available in Greater Zurich. In addition, there are renowned universities that also attract international students and future top professionals. Switzerland has a very good dual education system and benefits from the multilingualism of many experts. Compared to other medtech locations, Switzerland stands out.

Biotech in the Greater Zurich Area

Biotech in the Greater Zurich Area

The Greater Zurich Area is one of the leading locations for biotechnology and pharmaceutical companies in Europe. The region is home to the innovative companies in the world, from Biogen and Johnson & Johnson to Roche and Amgen, and attracts capital and researchers from all over the world. 

BioTech Teaser

Want to be part of this thriving medtech ecosystem? Reach out:

Lukas Sieber Portrait
Lukas Sieber
Executive Director USA
Beryl Kern Portrait
Beryl Kern
Senior Project Manager
Rolf Bühler Portrait
Rolf Bühler
Director Europe

Success stories

Contact us

Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center?